Pediatric Non-Hodgkin Lymphomas (NHL) are a diverse group of malignancies and as such treatment can vary based on the different biological characteristics of each malignancy. Significant advancements are being made in the treatment and outcomes of this group of malignancies. This is in large part due to novel targeted drug therapies that are being used in combination with traditional chemotherapy. Here, we discuss several new lines of therapy that are being developed or are in current use for pediatric patients with NHL.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932546 | PMC |
| http://dx.doi.org/10.3390/ph9020028 | DOI Listing |
Publication Analysis
Top Keywords
pediatric non-hodgkin
8
non-hodgkin lymphomas
8
group malignancies
8
targeted therapies
4
therapies treatment
4
treatment pediatric
4
lymphomas future
4
future pediatric
4
lymphomas nhl
4
nhl diverse
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!